Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine

Tai, Wanbo, He, Lei, Zhang, Xiujuan, Pu, Jing, Voronin, Denis, Jiang, Shibo, Zhou, Yusen, Du, Lanying·2020·Cellular & Molecular Immunology
DOI 10.1038/s41423-020-0400-4

Cited by (1,001)

Items 501–600 of 1,001

  1. Virus‐Free and Live‐Cell Visualizing SARS‐CoV‐2 Cell Entry for Studies of Neutralizing Antibodies and Compound Inhibitors
    Yali Zhang, Shaojuan Wang, Yangtao Wu, Wangheng Hou, Lunzhi Yuan, Chenguang Shen, Juan Wang, Jianghui Ye, Qingbing Zheng, Jian Ma et al. · 2020 · Small Methods
  2. Biological characteristics and biomarkers of novel SARS-CoV-2 facilitated rapid development and implementation of diagnostic tools and surveillance measures
    Gajanan Sampatrao Ghodake, Surendra Krushna Shinde, Avinash Ashok Kadam, Rijuta Ganesh Saratale, Ganesh Dattatraya Saratale, Asad Syed, Abdallah Mohamed Elgorban, Najat Marraiki, Dae-Young Kim · 2021 · Biosensors and Bioelectronics
  3. A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor
    Sajjan Rajpoot, Tomokazu Ohishi, Ashutosh Kumar, Qiuwei Pan, Sreeparna Banerjee, Kam Y. J. Zhang, Mirza S. Baig · 2021 · Drugs in R&D
  4. Epitope Profiling Reveals the Critical Antigenic Determinants in SARS-CoV-2 RBD-Based Antigen
    Min Jiang, Gaiping Zhang, Hongliang Liu, Peiyang Ding, Yunchao Liu, Yuanyuan Tian, Yanwei Wang, Aiping Wang · 2021 · Frontiers in Immunology
  5. Microfluidic-based technologies for diagnosis, prevention, and treatment of COVID-19: recent advances and future directions
    E. Alperay Tarim, Müge Anıl-İnevi, Ilayda Ozkan, Seren Keçili, Eyüp Bilgi, M. Semih Baslar, Engin Özçivici, Ceyda Öksel Karakuş, Huseyin Cumhur Tekin · 2023 · Biomedical Microdevices
  6. Structural understanding of SARS-CoV-2 virus entry to host cells
    Kim Phuong Uyen Le, Shrute Kannappan, Truc Kim, Jung Heon Lee, Hye-Ra Lee, Kyeong Kyu Kim · 2023 · Frontiers in Molecular Biosciences
  7. AlphaFold2 Modeling and Molecular Dynamics Simulations of the Conformational Ensembles for the SARS-CoV-2 Spike Omicron JN.1, KP.2 and KP.3 Variants: Mutational Profiling of Binding Energetics Reveals Epistatic Drivers of the ACE2 Affinity and Escape Hotspots of Antibody Resistance
    Nishank Raisinghani, Mohammed Alshahrani, Grace Gupta, Gennady M. Verkhivker · 2024 · Viruses
  8. Recovery of Rare Earth Elements ( REEs ) From Different Sources of E‐Waste and Their Potential Applications: A Focused Review
    Rohit Kumar Dev, Shiv Narayan Yadav, Nisha Magar, Srijana Ghimire, Mahima Koirala, Rijan Giri, Ashok Kumar Das, Sujit Kumar Shah, Ramesh L. Gardas, Ajaya Bhattarai · 2025 · Geological Journal
  9. New disease old vaccine: Is recombinant BCG vaccine an answer for COVID-19?
    Pramod Kumar Gupta · 2020 · Cellular Immunology
  10. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a newly emerged pathogen: an overview
    Jitendra Singh Rathore, Chaitali Ghosh · 2020 · Pathogens and Disease
  11. SARS-CoV-2: a new dimension to our understanding of coronaviruses
    Yusha Araf, Nairita Ahsan Faruqui, Saeed Anwar, Mohammad Jakir Hosen · 2020 · International Microbiology
  12. A review on the interaction of nucleoside analogues with SARS-CoV-2 RNA dependent RNA polymerase
    Suliman Khan, Farnoosh Attar, Samir Haj Bloukh, Majid Sharifi, Faisal Nabi, Qian Bai, Rizwan Hasan Khan, Mojtaba Falahati · 2021 · International Journal of Biological Macromolecules
  13. Fundamental evolution of all Orthocoronavirinae including three deadly lineages descendent from Chiroptera‐hosted coronaviruses: SARS‐CoV, MERS‐CoV and SARS‐CoV‐2
    Denis Jacob Machado, Rachel Scott, Sayal Guirales-Medrano, Daniel A. Janies · 2021 · Cladistics
  14. Human cell receptors: potential drug targets to combat COVID-19
    Pawan Kumar Raghav, Keerthana Kalyanaraman, Dinesh Kumar · 2021 · Amino Acids
  15. Generation of potent cellular and humoral immunity against SARS-CoV-2 antigens via conjugation to a polymeric glyco-adjuvant
    Laura T. Gray, Michal M. Raczy, Priscilla S. Briquez, Tiffany M. Marchell, Aaron T. Alpar, Rachel P. Wallace, Lisa R. Volpatti, Maria Stella Sasso, Shijie Cao, Mindy Nguyen et al. · 2021 · Biomaterials
  16. COVID-19 and Diabetes: A Comprehensive Review of Angiotensin Converting Enzyme 2, Mutual Effects and Pharmacotherapy
    Lingli Xie, Ziying Zhang, Qian Wang, Yangwen Chen, Dexue Lu, Weihua Wu · 2021 · Frontiers in Endocrinology
  17. Computational prediction of the effect of mutations in the receptor-binding domain on the interaction between SARS-CoV-2 and human ACE2
    İsmail Çeli̇k, Abbas Khan, Fenny Martha Dwivany, Fatimawali Fatimawali, Dong‐Qing Wei, Trina Ekawati Tallei · 2022 · Molecular Diversity
  18. Euphorbia hirta as a gold mine of high-value phytochemicals: A comprehensive review of its pharmacological activities and possible role against SARS-CoV-2
    Aadil Khursheed, Vikrant Jain, Ab Rouf Wani · 2022 · Biomedical Research and Therapy
  19. Calprotectin and Imbalances between Acute-Phase Mediators Are Associated with Critical Illness in COVID-19
    Georgios Kassianidis, Athanasios Siampanos, Garyphalia Poulakou, George Adamis, Aggeliki Rapti, Haralampos J. Milionis, George Ν. Dalekos, Vasileios Petrakis, Styliani Sympardi, Symeon Metallidis et al. · 2022 · International Journal of Molecular Sciences
  20. Innate and adaptive immunity to SARS-CoV-2 and predisposing factors
    Jiaying Shen, Junyan Fan, Yue Zhao, Doming Jiang, Zheyun Niu, Zihan Zhang, Guangwen Cao · 2023 · Frontiers in Immunology
  21. Mutation Hot Spots in Spike Protein of COVID-19
    Arup Kumar Banerjee, Feroza Begum, Upasana Ray · 2020 · Preprints.org
  22. A Generalized Overview of SARS-CoV-2: Where Does the Current Knowledge Stand?
    Md. Asad Ullah, Hiya Islam, Ahsab Rahman, Jaasia Masud, Dipita Saha Shweta, Yusha Araf, Syed Muktadir Al Sium, Bishajit Sarkar · 2020 · Electronic Journal of General Medicine
  23. OUP accepted manuscript
    Mugurel Apetrii, Ștefana Enachi, Dimitrie Cristian Siriopol, Alexandru Burlacu, Asiye Kanbay, Mehmet Kanbay, Dragoş Viorel Scripcariu, Adrian Constantin Covic · 2020 · Clinical Kidney Journal
  24. Coronavirus disease 2019 (COVID-19): latest developments in potential treatments
    Kam‐Lun Ellis Hon, Karen Ka Yan Leung, Alexander K. C. Leung, Su Yun Qian, Vivian Pui Ying Chan, Patrick Ip, Ian Chi Kei Wong · 2020 · Drugs in Context
  25. A graph-based approach identifies dynamic H-bond communication networks in spike protein S of SARS-CoV-2
    Konstantina Karathanou, Michalis Lazaratos, Éva Bertalan, Malte Siemers, Krzysztof Buzar, Gebhard F. X. Schertler, Coral del Val, Ana‐Nicoleta Bondar · 2020 · Journal of Structural Biology
  26. Recent findings on the Coronavirus disease 2019 (COVID-19); immunopathogenesis and immunotherapeutics
    Negin Ebrahimi, Saeed Aslani, Farhad Babaie, Maryam Hemmatzadeh, Ramin Hosseinzadeh, Zeinab Joneidi, Zahra Mehdizadeh Tourzani, Nafiseh Pakravan, Hamed Mohammadi · 2020 · International Immunopharmacology
  27. Is a healthy microbiome responsible for lower mortality in COVID-19?
    Ľubomír Janda, Matúš Mihalčin, Michaela Šťastná · 2020 · Biologia
  28. Level of the SARS-CoV-2 receptor ACE2 activity is highly elevated in old-aged patients with aortic stenosis: implications for ACE2 as a biomarker for the severity of COVID-19
    Miklós Fagyas, Attila Kertész, Ivetta Mányiné Siket, Viktor Bánhegyi, Bertalan Kracskó, Andrea Szegedi, M Szokol, Gusztáv Vajda, Ildikó Rácz, Hajnalka Gulyás et al. · 2021 · GeroScience
  29. Effect of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) on reproductive system
    Nengzhuang Wang, Lina Qin, Long Ma, Hongli Yan · 2021 · Stem Cell Research
  30. COVID-19 infection and nanomedicine applications for development of vaccines and therapeutics: An overview and future perspectives based on polymersomes
    Mohammad A. I. Al-Hatamleh, Ma’mon M. Hatmal, Walhan Alshaer, Engku Nur Syafirah Engku Abd Rahman, Manali Haniti Mohd-Zahid, Dina M. Alhaj-Qasem, Chan Yean Yean, Iskandar Zulkarnain Alias, Juhana Jaafar, Khalid Ferji et al. · 2021 · European Journal of Pharmacology
  31. BNT162b2 mRNA COVID‐19 vaccine induces antibodies of broader cross‐reactivity than natural infection, but recognition of mutant viruses is up to 10‐fold reduced
    Xinyue Chang, Gilles Sousa Augusto, Xuelan Liu, Thomas M. Kündig, Monique Vogel, Mona Omar Mohsen, Martin F. Bachmann · 2021 · Allergy
  32. Comparative Immunomodulatory Evaluation of the Receptor Binding Domain of the SARS-CoV-2 Spike Protein; a Potential Vaccine Candidate Which Imparts Potent Humoral and Th1 Type Immune Response in a Mouse Model
    Tripti Shrivastava, Balwant Singh, Zaigham Abbas Rizvi, Rohit Verma, Sandeep Goswami, Preeti Vishwakarma, Kamini Jakhar, Sudipta Sonar, Shailendra Mani, Sankar Bhattacharyya et al. · 2021 · Frontiers in Immunology
  33. Neutralizing Aptamers Block S/RBD‐ACE2 Interactions and Prevent Host Cell Infection
    Xiaohui Liu, Yi‐ling Wang, Jacky Wu, Jianjun Qi, Zihua Zeng, Quanyuan Wan, Zhenghu Chen, Pragya Manandhar, Victoria S. Cavener, Nina R. Boyle et al. · 2021 · Angewandte Chemie
  34. End-to-End Protein Normal Mode Frequency Predictions Using Language and Graph Models and Application to Sonification
    Yiwen Hu, Markus J. Buehler · 2022 · ACS Nano
  35. The SARS-CoV-2 Spike Protein Activates the Epidermal Growth Factor Receptor-Mediated Signaling
    Abdul Rasheed Palakkott, Aysha Hamad Alneyadi, Khalid Muhammad, Ali Hussein Eid, Khaled M. A. Amiri, Mohammed Akli Ayoub, Rabah Iratni · 2023 · Vaccines
  36. Advances in SARS-CoV-2 receptor-binding domain-based COVID-19 vaccines
    Xiaoqing Guan, Yang Yang, Lanying Du · 2023 · Expert Review of Vaccines
  37. Recombinant SARS-CoV-2 Spike Protein and Its Receptor Binding Domain Stimulate Release of Different Pro-Inflammatory Mediators via Activation of Distinct Receptors on Human Microglia Cells
    Irene Tsilioni, Theoharis Constantin Theoharides · 2023 · Molecular Neurobiology
  38. mRNA COVID-19 vaccine elicits potent adaptive immune response without the persistent inflammation seen in SARS-CoV-2 infection
    Ellie N. Ivanova, Jasmine Shwetar, Joseph Cooper Devlin, Terkild B. Buus, Sophie L. Gray-Gaillard, Akiko Koide, Amber R. Cornelius, Marie I. Samanovic, Alberto M. Herrera, Eleni P. Mimitou et al. · 2021 · medRxiv
  39. Dynamics of antibody response to BNT162b2 mRNA COVID-19 vaccine after 6 months
    D. Ponticelli, Ippazio Cosimo Antonazzo, Grazia Caci, Andrea Vitale, Giovanni Della Ragione, Maria L. Romano, Mario Borrelli, Beniamino Schiavone, Riccardo Polosa, Pietro Ferrara · 2021 · Journal of Travel Medicine
  40. Electrochemical biosensing based comparative study of monoclonal antibodies against SARS-CoV-2 nucleocapsid protein
    Maryia Drobysh, Viktorija Liustrovaitė, Yahor Kanetski, Benediktas Brasiūnas, Aurelija Žvirblienė, Agnė Rimkutė, Dainius Gudas, Indrė Kučinskaitė-Kodzė, Martynas Simanavičius, Simonas Ramanavičius et al. · 2023 · The Science of The Total Environment
  41. Therapeutic nanobodies against SARS-CoV-2 and other pathogenic human coronaviruses
    Yang Yang, Fang Li, Lanying Du · 2024 · Journal of Nanobiotechnology
  42. COVID-19 and Liver Damage
    L. Yu. Ilchenko, Igor Gennadievich Nikitin, И. Г. Федоров · 2020 · The Russian Archives of Internal Medicine
  43. A Multi-Targeting Approach to Fight SARS-CoV-2 Attachment
    Luciano Pirone, Annarita Del Gatto, Sonia Di Gaetano, Michele Saviano, Domenica Capasso, Laura Zaccaro, Emilia Maria Pedone · 2020 · Frontiers in Molecular Biosciences
  44. A computational approach to drug repurposing against SARS-CoV-2 RNA dependent RNA polymerase (RdRp)
    Giovanni Ribaudo, Alberto Ongaro, Erika Oselladore, Giuseppe Zagotto, Maurizio Memo, Alessandra Gianoncelli · 2020 · Journal of Biomolecular Structure and Dynamics
  45. A review on the effect of COVID-19 in type 2 asthma and its management
    Srijit Ghosh, Srijita Das, Rupsa Mondal, Salik Abdullah, Shirin Sultana, Sukhbir Singh, Aayush Sehgal, Tapan Behl · 2020 · International Immunopharmacology
  46. Viral Infection and Cardiovascular Disease: Implications for the Molecular Basis of COVID-19 Pathogenesis
    Sarah Seeherman, Yuichiro Suzuki · 2021 · International Journal of Molecular Sciences
  47. Broad-Spectrum Anti-coronavirus Vaccines and Therapeutics to Combat the Current COVID-19 Pandemic and Future Coronavirus Disease Outbreaks
    Miao Cao, Xiaojie Su, Shibo Jiang · 2021 · Stem Cell Reports
  48. A SARS-CoV-2 Label-Free Surrogate Virus Neutralization Test and a Longitudinal Study of Antibody Characteristics in COVID-19 Patients
    Yi-Qi R. Luo, C. Yun, I. Chakraborty, A. Wu, K. Lynch · 2021 · Journal of Clinical Microbiology
  49. Structure‐ and Interaction‐Based Design of Anti‐SARS‐CoV‐2 Aptamers
    Vladimir Mironov, Щугорева Ирина Андреевна, Polina V. Artyushenko, Dmitry I. Morozov, Nicola Borbone, Giorgia Oliviero, Tatiana N. Zamay, Roman V. Moryachkov, Olga S. Kolovskaya, Kirill A. Lukyanenko et al. · 2022 · Chemistry - A European Journal
  50. A Randomized Trial of Sitagliptin and Spironolactone With Combination Therapy in Hospitalized Adults With COVID-19
    Farhad Abbasi, Reuben Adatorwovor, Mohammad Ali Davarpanah, Yasaman Mansoori, Mehdi Hajiani, Farzan Azodi, Sepideh Sefidbakht, Shayesteh Davoudi, Farzana Rezaei, Shayan Mohammadmoradi et al. · 2022 · Journal of the Endocrine Society
  51. Whole-genome sequencing of SARS-CoV-2 reveals diverse mutations in circulating Alpha and Delta variants during the first, second, and third waves of COVID-19 in South Kivu, east of the Democratic Republic of the Congo
    Patrick N. Bisimwa, Samuel O. Oyola, Simon Patrick Baenyi, Gilbert Kibet, Ahadi Bwihangane Birindwa, Dieudonné Shukuru Wasso, Tshass Chasinga Baharanyi, Théophile Mitima Kashosi, Jean Paul Buhendwa Cikwanine, Parvine Basimane Bisimwa et al. · 2022 · International Journal of Infectious Diseases
  52. Placental vascular remodeling in pregnant women with COVID-19
    Sergiy G. Gychka, Tinatin I. Brelidze, Iurii L. Kuchyn, Tetiana Savchuk, Sofia I. Nikolaienko, Volodymyr M. Zhezhera, Ihor I. Chermak, Yuichiro Suzuki · 2022 · PLoS ONE
  53. Sertraline Is an Effective SARS-CoV-2 Entry Inhibitor Targeting the Spike Protein
    Yuliu Chen, Yan Wu, Shaoying Chen, Qingping Zhan, Dingzhou Wu, Chan Yang, Xiaoxue He, Mengjie Qiu, Nannan Zhang, Zhaofeng Li et al. · 2022 · Journal of Virology
  54. Nanovaccines for Advancing Long-Lasting Immunity against Infectious Diseases
    Xinglong Gao, Xinlian Wang, Shilin Li, Muhammad Saif Ur Rahman, Shanshan Xu, Ying Liu · 2023 · ACS Nano
  55. Current laboratory diagnosis of coronavirus disease 2019
    Jihyang Lim, Jehoon Lee · 2020 · The Korean Journal of Internal Medicine
  56. Bacterial protein azurin and derived peptides as potential anti-SARS-CoV-2 agents: insights from molecular docking and molecular dynamics simulations
    Santanu Sasidharan, Chandrabose Selvaraj, Sanjeev Kumar Singh, Vikash Kumar Dubey, Sachin Kumar, Arsénio M. Fialho, Prakash Saudagar · 2020 · Journal of Biomolecular Structure and Dynamics
  57. Progress in the Research and Development of Anti-COVID-19 Drugs
    Lianzhou Huang, Yuanqiu Chen, Ji Xiao, Weisheng Luo, Li Feng, Yuan Wang, Yiliang Wang, Yifei Wang · 2020 · Frontiers in Public Health
  58. Single‐cell RNA sequencing analysis of SARS‐CoV‐2 entry receptors in human organoids
    Rajasekaran Mahalingam, Prakash Dharmalingam, Abirami Santhanam, Sivareddy Kotla, Gangarao Davuluri, Harry Karmouty‐Quintana, Ashrith Guha, Rajarajan A. Thandavarayan · 2020 · Journal of Cellular Physiology
  59. Kerja Harmoni Zat Gizi dalam Meningkatkan Imunitas Tubuh Terhadap Covid-19: Mini Review
    Sri Sumarmi · 2020 · Amerta Nutrition
  60. A comprehensive SARS-CoV-2 genomic analysis identifies potential targets for drug repurposing
    Nithishwer Mouroug Anand, Devang Haresh Liya, Arpit Kumar Pradhan, Nitish Tayal, Abhinav Bansal, Sainitin Donakonda, Ashwin Jainarayanan · 2021 · PLoS ONE
  61. Azithromycin and ambroxol as potential pharmacotherapy for SARS-CoV-2
    Myasar Mohammed Alkotaji · 2020 · International Journal of Antimicrobial Agents
  62. Serological Test to Determine Exposure to SARS-CoV-2: ELISA Based on the Receptor-Binding Domain of the Spike Protein (S-RBDN318-V510) Expressed in Escherichia coli
    Alan Roberto Márquez-Ipiña, Everardo Gonzalez‐González, Iram Pablo Rodriguez-Sanchez, Itzel Montserrat Lara-Mayorga, Luis Alberto Mejía‐Manzano, Mónica Gabriela Sánchez-Salazar, José González‐Valdez, Rocio Ortı́z-López, Augusto Rojas‐Martínez, Grissel Trujillo‐de Santiago et al. · 2021 · Diagnostics
  63. Bell's Palsy as a Late Neurologic Manifestation of COVID-19 Infection
    Ibiyemi O Oke, Olubunmi O. Oladunjoye, Adeolu Olufunso Oladunjoye, Anish Paudel, Ryan P. Zimmerman · 2021 · Cureus
  64. COVID19-inhibitory activity of withanolides involves targeting of the host cell surface receptor ACE2: insights from computational and biochemical assays
    Rajkumar Singh Kalra, Vipul Kumar, Jaspreet Kaur Dhanjal, Sukant Garg, Xiaoshuai Li, Sunil C. Kaul, Durai Sundar, Renu Wadhwa · 2021 · Journal of Biomolecular Structure and Dynamics
  65. Key Considerations for the Development of Safe and Effective SARS‐CoV‐2 Subunit Vaccine: A Peptide‐Based Vaccine Alternative
    Ahmed O. Shalash, Waleed M. Hussein, Mariusz Skwarczyński, István Tóth · 2021 · Advanced Science
  66. Potential natural products that target the SARS-CoV-2 spike protein identified by structure-based virtual screening, isothermal titration calorimetry and lentivirus particles pseudotyped (Vpp) infection assay
    Guanyu Chen, Yi‐Cheng Pan, Tung‐Ying Wu, Tsung-You Yao, Wei‐Jan Wang, Wan‐Jou Shen, Azaj Ahmed, Shu-Ting Chan, Chih‐Hsin Tang, Wei‐Chien Huang et al. · 2021 · Journal of Traditional and Complementary Medicine
  67. Untargeted Metabolic Profiling of Extracellular Vesicles of SARS-CoV-2-Infected Patients Shows Presence of Potent Anti-Inflammatory Metabolites
    Faisal A. Alzahrani, Mohammed Razeeth Shait Mohammed, Saleh Alkarim, Esam I. Azhar, Mohammed A. El‐Magd, Yousef MohammedRabaa Hawsawi, Wesam Hussain Abdulaal, Abdulaziz Yusuf, Abdulaziz Alhatmi, Raed S. Albiheyri et al. · 2021 · International Journal of Molecular Sciences
  68. The Nuts and Bolts of SARS-CoV-2 Spike Receptor-Binding Domain Heterologous Expression
    Mariano Maffei, Linda Celeste Montemiglio, Grazia Vitagliano, Luigi Fedele, Shaila Sellathurai, Federica Bucci, Mirco Compagnone, Valerio Chiarini, Cécile Exertier, Alessia Muzi et al. · 2021 · Biomolecules
  69. Evaluation of serological anti-SARS-CoV-2 chemiluminescent immunoassays correlated to live virus neutralization test, for the detection of anti-RBD antibodies as a relevant alternative in COVID-19 large-scale neutralizing activity monitoring
    Antonio Cristiano, Massimo Pieri, Serena Sarubbi, Martina Pelagalli, Graziella Calugi, Flaminia Tomassetti, Sergio Bernardini, Marzia Nuccetelli · 2021 · Clinical Immunology
  70. Development of an LNP-Encapsulated mRNA-RBD Vaccine against SARS-CoV-2 and Its Variants
    Cong Liu, Nino Rcheulishvili, Zhigao Shen, Dimitri Papukashvili, Fengfei Xie, Ziqian Wang, Xingyun Wang, Yunjiao He, Peng George Wang · 2022 · Pharmaceutics
  71. NMR Experiments Provide Insights into Ligand-Binding to the SARS-CoV-2 Spike Protein Receptor-Binding Domain
    Robert Creutznacher, Thorben Maaß, Barbora Veselková, George Liam Ssebyatika, Thomas Krey, Martin Empting, Norbert Tautz, Martin Frank, Knut Kölbel, Charlotte Uetrecht et al. · 2022 · Journal of the American Chemical Society
  72. Coronavirus Disease 2019 (COVID-19): Current Situation and Therapeutic Options
    Veer Singh, Vishal Mishra · 2020 · Coronaviruses
  73. Unveiling the Potential: High-Affinity aptamers for point of care detection of SARS-CoV-2 RBD protein and it’s validation in clinical samples
    Narlawar Sagar Shrikrishna, Sayanti Halder, Veerbhan Kesarwani, Kammilli Nagamani, Sonu Gandhi · 2024 · Chemical Engineering Journal
  74. Acetylated K676 TGFBIp as a severity diagnostic blood biomarker for SARS-CoV-2 pneumonia
    Hee Ho Park, Hong Nam Kim, Hyelim Kim, Youngbum Yoo, Hyosoo Shin, Eun Young Choi, Jong‐Sup Bae, Wonhwa Lee · 2020 · Science Advances
  75. Animal coronaviruses and coronavirus disease 2019: Lesson for One Health approach
    Uddab Poudel, Deepak Subedi, Saurav Pantha, Santosh Dhakal · 2020 · Open Veterinary Journal
  76. Druggable targets from coronaviruses for designing new antiviral drugs
    Leandro Rocha Silva, Paulo Fernando da Silva Santos-Júnior, Júlia de Andrade Brandão, Letícia Anderson, Ênio José Bassi, João Xavier de Araújo‐Júnior, Sílvia Helena Cardoso, Edeildo Ferreira da Silva‐Júnior · 2020 · Bioorganic & Medicinal Chemistry
  77. Identification of novel mutations in SARS-COV-2 isolates from Turkey
    Shazia Rehman, Tariq Mahmood, Ejaz Aziz, Riffat Batool · 2020 · Archives of Virology
  78. Amino acid interacting network in the receptor-binding domain of SARS-CoV-2 spike protein
    Puja Adhikari, W. Y. Ching · 2020 · RSC Advances
  79. Molecular Dynamics Reveals Complex Compensatory Effects of Ionic Strength on the Severe Acute Respiratory Syndrome Coronavirus 2 Spike/Human Angiotensin-Converting Enzyme 2 Interaction
    Anacleto Silva de Souza, José D. Rivera, Vitor M. Almeida, Pingju Ge, Robson Francisco de Souza, Chuck S. Farah, Henning Ulrich, Sandro R. Marana, Roberto Köpke Salinas, Cristiane Rodrigues Guzzo · 2020 · The Journal of Physical Chemistry Letters
  80. Detection of SARS-CoV-2 Antibodies in Oral Fluid Obtained Using a Rapid Collection Device
    Melanie A. MacMullan, Prithivi Chellamuthu, Aubree Mades, Sudipta Sekhar Das, Fred Turner, Vladimir I. Slepnev, Albina Ibrayeva · 2020 · Journal of Clinical Microbiology
  81. Nanoluciferase complementation-based bioreporter reveals the importance of N-linked glycosylation of SARS-CoV-2 S for viral entry
    Taha Azad, Ragunath Singaravelu, Zaid Taha, Taylor R. Jamieson, Stephen Boulton, Mathieu J. F. Crupi, Nikolas Tim Martin, Emily E.F. Fekete, Joanna Poutou, Mina Ghahremani et al. · 2021 · Molecular Therapy
  82. Strategies for Immunomonitoring after Vaccination and during Infection
    Lucille Adam, Pierre Rosenbaum, Olivia Bonduelle, Béhazine Combadière · 2021 · Vaccines
  83. The therapeutic potential of inorganic polyphosphate: A versatile physiological polymer to control coronavirus disease (COVID-19)
    Hadrian Schepler, Xiaohong Wang, Meik Neufurth, Shunfeng Wang, Heinz Christoph Schröder, Wernér E.G. Müller · 2021 · Theranostics
  84. Computational and experimental insights on the interaction of artemisinin, dihydroartemisinin and chloroquine with SARS-CoV-2 spike protein receptor-binding domain (RBD)
    Giovanni Ribaudo, Paolo Saul Coghi, Li Yang, Jerome P. L. Ng, Andrea Mastinu, Maurizio Memo, Vincent Kam Wai Wong, Alessandra Gianoncelli · 2021 · Natural Product Research
  85. COVID-19 and pulmonary fibrosis: therapeutics in clinical trials, repurposing, and potential development
    Joowon Yim, Hee Hyun Lim, Youngjoo Kwon · 2021 · Archives of Pharmacal Research
  86. SARS-CoV 2 spike protein S1 subunit as an ideal target for stable vaccines: A bioinformatic study
    Somakalahalli Narasimhappa Nagesha, Ramesh B.N., Chalapathi Pradeep, K. S. Shashidhara, Thippeswamy Ramakrishnappa, Krishnaprasad B.T., Jnanashree S.M., Manohar M., Arunkumar N., Yallappa et al. · 2021 · Materials Today Proceedings
  87. COVID-19: A review of newly formed viral clades, pathophysiology, therapeutic strategies and current vaccination tasks
    Chandran Murugan, Sharmiladevi Ramamoorthy, Guru Prasad Kuppuswamy, Rajesh Kumar Murugan, Yuvaraj Sivalingam, Anandhakumar Sundaramurthy · 2021 · International Journal of Biological Macromolecules
  88. Methylxanthines as Potential Inhibitor of SARS-CoV-2: an In Silico Approach
    Rajan Rolta, Deeksha Salaria, Bhanu Sharma, Oladoja Awofisayo, Olatomide Ayodeji Fadare, Sonum Sharma, Chirag Patel, Vikas Kumar, Anuradha Sourirajan, David J. Baumler et al. · 2022 · Current Pharmacology Reports
  89. Various vaccine platforms in the field of COVID-19
    Kus Fiani Savina, Rakhy Sreekumar, V K Soonu, E. Jayadevi Variyar · 2022 · Beni-Suef University Journal of Basic and Applied Sciences
  90. A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection
    Juan Shi, Jian Zheng, Wan-Bo Tai, A. K. Verma, Xiujuan Zhang, Q. Geng, Gang Wang, Xiaoqing Guan, M. Malisheni, Abby E. Odle et al. · 2022 · Journal of Virology
  91. A web-based Diagnostic Tool for COVID-19 Using Machine Learning on Chest Radiographs (CXR)
    Evariste B. Gueguim Kana, M. G. Zebaze Kana, Armand F. Donfack Kana, R.H. Azanfack Kenfack · 2020 · medRxiv
  92. Interaction Between Coronavirus S-Protein and Human ACE2: Hints for Exploring Efficient Therapeutic Targets to Treat COVID-19
    Amir Abbas Momtazi‐Borojeni, Maciej Banach, Željko Reiner, Matteo Pirro, Vanessa Bianconi, Khalid Al‐Rasadi, Amirhossein Sahebkar · 2020 · Angiology
  93. Glossary of phytoconstituents: Can these be repurposed against SARS CoV-2? A quick in silico screening of various phytoconstituents from plant Glycyrrhiza glabra with SARS CoV-2 main protease
    Iram Iqbal Hejazi, Md Amjad Beg, Md Ali Imam, Fareeda Athar, Asimul Islam · 2021 · Food and Chemical Toxicology
  94. Small molecule therapeutics to destabilize the ACE2-RBD complex: A molecular dynamics study
    Meghdad Razizadeh, Mehdi Nikfar, Yaling Liu · 2021 · Biophysical Journal
  95. Computational design of SARS-CoV-2 peptide binders with better predicted binding affinities than human ACE2 receptor
    Thassanai Sitthiyotha, Surasak Chunsrivirot · 2021 · Scientific Reports
  96. Changes in the SARS-CoV-2 cellular receptor ACE2 levels in cardiovascular patients: a potential biomarker for the stratification of COVID-19 patients
    Miklós Fagyas, Viktor Bánhegyi, Úri Katalin, Attila Enyedi, Erzsébet Lizanecz, Ivetta Siket Mányiné, Lilla Mártha, Gábor Áron Fülöp, Tamás Radovits, Miklós Pólos et al. · 2021 · GeroScience
  97. Mechanistic insights into the effects of key mutations on SARS-CoV-2 RBD–ACE2 binding
    Abhishek Aggarwal, Supriyo Naskar, Nikhil Maroli, Biswajit Gorai, Narendra M. Dixit, Prabal Kumar Maiti · 2021 · Physical Chemistry Chemical Physics
  98. Naringenin as a Possible Candidate Against SARS-CoV-2 Infection and in the Pathogenesis of COVID-19
    Pawan Kumar Agrawal, Chandan Agrawal, Gerald Blunden · 2021 · Natural Product Communications
  99. Nanomaterials and metal-organic frameworks for biosensing applications of mutations of the emerging viruses
    Sheta M. Sheta, Said M. El‐Sheikh · 2022 · Analytical Biochemistry
  100. Investigation of potential inhibitor properties of violacein against HIV-1 RT and CoV-2 Spike RBD:ACE-2
    Merve Ayşe Doğancı, Fulya Ay Sal, Halil İbrahim Güler, Hatice Katı, Esma Ceylan, Ali Osman Beldüz, Gözde Bozdal, Nurettin Yaylı, Sabriye Çanakçı · 2022 · World Journal of Microbiology and Biotechnology